Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.61 | N/A |
| PEG Ratio (TTM) | -0.94 | N/A |
| P/S Ratio (TTM) | 0.99 | N/A |
| P/B Ratio (TTM) | 0.91 | N/A |
| P/FCF Ratio (TTM) | 16.18 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.47 | N/A |
| Price to 5YR AVG FCF Ratio | 12.25 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.69% | N/A |
| ROE (TTM) | 6.71% | N/A |
| Net Profit Margin (TTM) | 7.25% | N/A |
| ROIC 5YR AVG | 9.45% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.28% | 44.96% | 11.99% |
| Revenue | 2.22% | 14.09% | 3.78% |
| Net Income | -14.20% | 77.96% | 32.15% |
| Cash Flow | 39.28% | 930.76% | 557.33% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.07 | N/A |
| Quick Ratio (TTM) | 2.72 | N/A |
| D/E Ratio (TTM) | 0.60 | N/A |
| Interest Coverage (TTM) | 6.33 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.76 | N/A |
| LTL to 5YR AVG FCF | 11.96 | N/A |
| Shares Outstanding Growth 5YR AVG | 16.24% | N/A |